CDC Reconsiders Hepatitis B Vaccines for Newborns—What Parents Should Know

Recent headlines about the hepatitis B (Hep B) vaccine have raised questions for many parents. On December 4–5, 2025, members of the CDC’s Advisory Committee on Immunization Practices (ACIP) voted to change the long-standing recommendation that all newborns receive a hepatitis B vaccine dose at birth—a guideline that has been in place in the U.S. for over 30 years.

Below is a clear, fact-based breakdown of what changed, why experts disagree, and what families should know while the CDC reviews the recommendation.

What Did ACIP Vote to Change?

During the December 2025 meeting, ACIP voted:

1. To recommend the Hep B birth dose only for infants whose mothers test positive or whose status is unknown.

This rolls back the universal birth-dose recommendation used since 1991.

2. To allow families and physicians to delay the birth dose until the 2-month visit for babies whose mothers test negative.

3. To evaluate blood antibody levels after each Hep B shot to determine whether a child needs all three doses.

Some children may receive fewer than three doses, although current vaccine studies were conducted using the full 3-dose schedule.

These changes will not take effect until the CDC’s acting director formally approves or rejects the recommendations.

Why Is This Recommendation Controversial?

The vote produced significant disagreement among medical, pediatric, and infectious disease experts who spoke at the meeting.

Concerns raised by members who supported the change

• They argued that most babies face a low immediate risk of hepatitis B infection.
• They questioned whether decades-old safety studies in newborns should be re-examined.
• They emphasized the desire for more “shared decision-making” between parents and physicians.

Concerns raised by medical and public health leaders

Many organizations — including infectious disease specialists, pediatricians, and hepatitis researchers — strongly objected. Their concerns included:

1. Universal birth vaccination has been extremely effective.

Since 1991, the U.S. has seen dramatic declines in childhood hepatitis B cases and related liver complications.

2. Risk-based strategies have historically missed at-risk infants.

Doctors note:

• Not all pregnant individuals receive timely hepatitis B testing.
• Test results can be incorrect, unavailable, or undocumented.
• Infants can contract hepatitis B through microscopic blood exposure, not just delivery.

3. There is no current evidence showing harm from the birth dose.

Experts stated that theoretical safety concerns were not supported by data.

4. Delaying the birth dose may lead to more infections.

Past experience shows that once a vaccine is optional or delayed, many infants never receive it.

Does This Contradict Existing CDC Evidence?

The September 2025 CDC “Hepatitis B Birth Dose Briefing Document” (used in ACIP’s earlier meeting) emphasized:

• Universal birth vaccination is the most reliable method to prevent early infections.
• Screening alone does not fully protect newborns.
• Missing even a small percentage of at-risk infants can lead to preventable chronic infections.

The document also reaffirmed that:

• The birth dose is considered safe,
• Evidence strongly supports the effectiveness of the existing 3-shot schedule.

The December 2025 vote does not overturn these findings—it simply reflects the perspectives of the current ACIP membership, which differs from past committees. The CDC’s acting director will now decide whether to uphold or reject this new guidance.

Why Is Hepatitis B Prevention So Important?

Hepatitis B is a viral infection that can cause:

• Chronic liver disease
• Liver cancer
• Cirrhosis
• Liver failure

Infants are at the highest risk of developing lifelong infection:

• Up to 90% of infected newborns become chronically infected
• Only a small percentage of infected adults develop chronic infection

Because early infection can occur without symptoms, prevention is considered a cornerstone of U.S. public health strategy.

What Should Parents Do Right Now?

Until the CDC issues a final decision:

1. The current recommendation remains in place:

All newborns should receive a Hepatitis B vaccine dose at birth.

2. Talk to your pediatrician or obstetric provider.

They can explain:

• Your hepatitis B status
• Your baby’s risk factors
• The benefits and safety data for the birth dose
• What changes might occur if the CDC adopts the new guideline

3. Follow guidance from medical organizations.

Independent groups such as:

• American Academy of Pediatrics (AAP)
• American Medical Association (AMA)
• Infectious Diseases Society of America (IDSA)
  continue to recommend universal birth vaccination, emphasizing its safety and effectiveness.

4. If you have concerns, ask for evidence.

Healthcare providers can show:

• Your test results
• Your baby’s vaccination schedule
• CDC safety data
• How hepatitis B spreads in real-world situations

The Bottom Line

The recent ACIP vote represents the most significant change to hepatitis B vaccine policy in more than 30 years. The decision has sparked strong reactions—not because parents are doing anything wrong, but because:

• The birth dose is widely seen as one of the most effective tools for preventing childhood hepatitis B.
• Many experts worry that weakening the recommendation may unintentionally increase infections.
• Others believe parents should have more room for individualized decision-making.

Until the CDC finalizes the policy, families should continue to rely on science-based guidance from pediatricians and established medical organizations.

Frequently Asked Questions

Q: Is the Hep B vaccine still recommended at birth?

Yes. Nothing has changed yet. The CDC must approve the new vote before guidelines shift.

Q: Is the Hep B vaccine safe for newborns?

Large studies over decades support its safety. Major medical groups continue to recommend the birth dose.

Q: Why does timing matter?

Infants are more vulnerable to chronic infection. Early protection helps prevent long-term liver disease.

Q: Can babies catch hepatitis B from casual contact?

Infants can be exposed through microscopic blood contact, which is why universal protection has been standard.

Q: What if a parent wants to wait?

Talk to your physician about your hepatitis B status and the risks of delaying the vaccine.